Liberty Wealth Management LLC Editas Medicine, Inc. Transaction History

Liberty Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$26.55 - $40.57 $26,550 - $40,570	-1,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$31.29 - $56.64 $1.74 Million - $3.15 Million	-55,640 Reduced 98.23%	1,000 $57,000
Q2 2021 Aug 13, 2021	BUY	$31.29 - $56.64 $1.74 Million - $3.15 Million	55,640 Added 5564.0%	56,640 $1 Million
Q2 2020 Aug 04, 2020	BUY	$18.5 - $34.34 $18,500 - $34,340	1,000 New	1,000 $30,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $144M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.